U.K. glass maker agrees to takeover by Japanese rival

Article Abstract:

Pilkington PLC of the United Kingdom is to be acquired by Nippon Sheet Glass of Japan for 2.2 billion Pounds ($3.8 billion). The Japanese glass maker already owns 20 percent of Pilkington PLC and will gain additional manufacturing plants in 24 countries with global sales in greater than 130 countries. The purchase illustrates a trend in international conglomerates picking up United Kingdom interests particularly in the construction business.

Japan, Engineering Services, Flat glass, Engineering for Glass & Ceramic Plants, Glass industry, Pilkington PLC, Company Profile, Nippon Sheet Glass Company Ltd.

---

MAN Chief takes softer tack on bid for rival Scania

Article Abstract:

Man AG of Germany has launched a $13 billion hostile bid offer for Scania AB of Sweden. The new truck making synergy would have the largest market share in Europe and would be the third largest truck and bus maker in the world.

Motor vehicles and car bodies, Management dynamics, Truck and bus bodies, Management, Truck industry, Germany, Sweden, Company business management, Scania AB, Maschinenfabrik Augsburg-Nurnberg AG, Company overview, Financial report, Samuelsson, Hakan

---

BAE agrees to acquire United Defense Industries

Article Abstract:

BAE SYSTEMS PLC has agreed to acquire United Defense Industries Inc. for $3.97 billion, increasing the British military contractors presence in the United States.

United States, Commodity & service prices, Securities issued, listed, Security brokers and dealers, Securities & Commodities Services, Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Guided Missiles, Space Vehicles, Parts, Prices and rates, Securities industry, Securities, Aerospace industry, BAE SYSTEMS PLC, UDI, Company securities, Company pricing policy, BAE Systems Inc. Land & Armaments Operating Group

Similar abstracts:

• Abstracts: Spain's Ferrovial may make offer for U.K.'s BAA. BAA rejects sweetened Ferrovial bid
• Abstracts: Novartis seeks approval to use Gleevec in four rare cancers. Sanofi aims to sell obesity drug this year, despite FDA setback

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.